Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xingqin Ganke Granule for post-cold cough
ChiCTR2400085269Phase 2Recruiting
- Sponsor
- Shuguang Hospital
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Xingqin Ganke Granules in postinfectious cough (3 arms), sponsored by Shuguang Hospital. Primary endpoints: Effective rate of cough and First resolution rate of cough. Started Jun 2024; status: recruiting.
02
Drugs
Xingqin Ganke Granules
03
Conditions
postinfectious cough
Beyond the preview
Go deeper on ChiCTR2400085269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085269.